Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes
Recent studies suggest a pathogenetic association between metabolic disturbances, including type 2 diabetes (T2DM), and cognitive decline and indicate that T2DM may represent a risk factor for Alzheimer’s disease (AD). There are a number of experimental studies presenting evidence that ranolazine, a...
Main Authors: | Velia Cassano, Martina Tallarico, Giuseppe Armentaro, Caterina De Sarro, Michelangelo Iannone, Antonio Leo, Rita Citraro, Emilio Russo, Giovambattista De Sarro, Marta Letizia Hribal, Angela Sciacqua |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/24/16160 |
Similar Items
-
Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture
by: Adrián Jordá, et al.
Published: (2022-10-01) -
Improvement of Vascular Insulin Sensitivity by Ranolazine
by: Sol Guerra-Ojeda, et al.
Published: (2023-08-01) -
RANOLAZINE IN ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01) -
Ranolazine Counteracts Strength Impairment and Oxidative Stress in Aged Sarcopenic Mice
by: Alessio Torcinaro, et al.
Published: (2022-07-01) -
Place of the novel drug ranolazine in the treatment of coronary artery disease
by: GA Baryshnikova, et al.
Published: (2014-12-01)